Vaccine Therapy in Treating Patients With Stage IV Melanoma
NCT00023647
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL:
Synchrotope TA2M
BIOLOGICAL:
Synchrotope TA2M
BIOLOGICAL:
Synchrotope TA2M
Sponsor
Mannkind Corporation